In our study, we selected a panel of 7‐TAAbs, including p53, GAGE7, PGP9.5, CAGE, MAGE A1, SOX2, and GBU4‐5, for the diagnosis of early‐stage NSCLC. This evidence concerns the gene TP53 and non-small cell lung carcinoma.